GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
12/06/25	GSK	11:00:00	12 Jun 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
27/06/22	GSK	16:08:13	27 Jun 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
24/06/22	GSK	15:44:50	24 Jun 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
16/06/22	GSK	10:58:21	16 Jun 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
10/06/22	GSK	07:00:08	10 Jun 2022	Positive phase III data for GSK’s RSV OA vaccine	GSK	Positive phase III data for GSK’s RSV OA vaccine	GSK PLC	RNS
09/06/22	GSK	16:28:40	9 Jun 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
07/06/22	GSK	17:17:08	7 Jun 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
06/06/22	GSK	07:00:09	6 Jun 2022	US FDA approval of Priorix	GSK	US FDA approval of Priorix	GSK PLC	RNS
01/06/22	GSK	16:55:33	1 Jun 2022	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
01/06/22	GSK	13:00:02	1 Jun 2022	Demerger update: Publication of Documents	GSK	Demerger update: Publication of Documents	GSK PLC	RNS
01/06/22	GSK	07:00:10	1 Jun 2022	Demerger update: Submission of Documents to FCA	GSK	Demerger update: Submission of Documents to FCA	GSK PLC	RNS
31/05/22	GSK	07:00:05	31 May 2022	GSK to acquire Affinivax, Inc.	GSK	GSK to acquire Affinivax, Inc.	GSK PLC	RNS
30/05/22	GSK	10:00:02	30 May 2022	Further appointments to Designate Haleon Board	GSK	Further appointments to Designate Haleon Board	GSK PLC	RNS
27/05/22	GSK	07:00:02	27 May 2022	GSK Cervarix two-dose schedule approved by NMPA	GSK	GSK Cervarix two-dose schedule approved by NMPA	GSK PLC	RNS
25/05/22	GSK	15:41:00	25 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
23/05/22	GSK	15:21:33	23 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
19/05/22	GSK	10:02:29	19 May 2022	Iain Mackay - External Appointment	GSK	Iain Mackay - External Appointment	GSK PLC	RNS
16/05/22	GSK	14:00:03	16 May 2022	Change of name to GSK plc	GSK	Change of name to GSK plc	GlaxoSmithKline PLC	RNS
13/05/22	GSK	17:13:23	13 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/05/22	GSK	08:58:18	12 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
11/05/22	GSK	17:17:19	11 May 2022	Block listing Interim Review	GSK	Block listing Interim Review	GlaxoSmithKline PLC	RNS
09/05/22	GSK	14:53:29	9 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
04/05/22	GSK	17:49:05	4 May 2022	Result of AGM	GSK	Result of AGM	GlaxoSmithKline PLC	RNS
04/05/22	GSK	10:00:02	4 May 2022	Directorate Change	GSK	Directorate Change	GlaxoSmithKline PLC	RNS
03/05/22	GSK	16:52:37	3 May 2022	Total Voting Rights	GSK	Total Voting Rights	GlaxoSmithKline PLC	RNS
27/04/22	GSK	07:00:09	27 Apr 2022	1st Quarter Results	GSK	1st Quarter Results	GlaxoSmithKline PLC	RNS
26/04/22	GSK	09:32:20	26 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
19/04/22	GSK	07:00:11	19 Apr 2022	Daprodustat application accepted for review by FDA	GSK	Daprodustat application accepted for review by FDA	GlaxoSmithKline PLC	RNS
14/04/22	GSK	14:23:40	14 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
14/04/22	GSK	14:15:56	14 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
14/04/22	GSK	13:29:25	14 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/04/22	GSK	17:11:56	13 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/04/22	GSK	09:32:16	13 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/04/22	GSK	07:00:12	13 Apr 2022	GSK agrees to acquire Sierra Oncology for $1.9bn	GSK	GSK agrees to acquire Sierra Oncology for $1.9bn	GlaxoSmithKline PLC	RNS
12/04/22	GSK	17:10:48	12 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/04/22	GSK	16:23:44	12 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/04/22	GSK	16:00:06	12 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/04/22	GSK	15:48:15	12 Apr 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
01/04/22	GSK	16:03:43	1 Apr 2022	Total Voting Rights	GSK	Total Voting Rights	GlaxoSmithKline PLC	RNS
01/04/22	GSK	11:20:21	1 Apr 2022	GSK - segment and product sales reporting changes	GSK	GSK - segment and product sales reporting changes	GlaxoSmithKline PLC	RNS
28/03/22	GSK	13:00:08	28 Mar 2022	Publication of 2022 AGM Notice	GSK	Publication of 2022 AGM Notice	GlaxoSmithKline PLC	RNS
24/03/22	GSK	15:22:58	24 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
24/03/22	GSK	14:00:04	24 Mar 2022	FDA update: Cabenuva oral lead-in now optional	GSK	FDA update: Cabenuva oral lead-in now optional	GlaxoSmithKline PLC	RNS
23/03/22	GSK	17:03:26	23 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
23/03/22	GSK	07:00:05	23 Mar 2022	Issuance of Notes	GSK	Issuance of Notes	GlaxoSmithKline PLC	RNS
16/03/22	GSK	14:40:34	16 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/03/22	GSK	14:45:52	15 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/03/22	GSK	10:00:02	15 Mar 2022	Appointments to Designate Haleon Board	GSK	Appointments to Designate Haleon Board	GlaxoSmithKline PLC	RNS
11/03/22	GSK	14:55:49	11 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
09/03/22	GSK	13:44:37	9 Mar 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS

Showing 901–950 of 2,803 announcements